Search results for “Plasmodium falciparum infection” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 37 patents, we discovered top 9 key players by total patent application. Regeneron Pharmaceuticals, Inc., Oxford University Innovation Ltd., Georgia State University Research Foundation, Inc. are dominant in this area. They take 70.27% of the total patent filing.
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 12
Oxford University Innovation Ltd.
United Kingdom
Patent: 8
Georgia State University Research Foundation, Inc.
Georgia, United States
Patent: 5
Glaxosmithkline Intellectual Property Development Ltd.
East Sussex, United Kingdom
Patent: 2
Unisearch Ltd.
Washington, United States
Patent: 1
Lipitek International, Inc.
Texas, United States
Patent: 1
Fundação de Amparo à Pesquisa do Estado de Minas Gerais
Minas Gerais, Brazil
Patent: 1
Merrell Dow Pharmaceuticals, Inc.
United States
Patent: 1
International Centre For Genetic Engineering & Biotechnology
Italy
Patent: 1
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 24 patents applied in the last 5 years. We discover 5 most active companies in this area. The fast-growing Regeneron Pharmaceuticals, Inc., Oxford University Innovation Ltd., Glaxosmithkline Intellectual Property Development Ltd. take 91.67% of patent filing during this period.
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 12
Oxford University Innovation Ltd.
United Kingdom
Patent: 8
Glaxosmithkline Intellectual Property Development Ltd.
East Sussex, United Kingdom
Patent: 2
Fundação de Amparo à Pesquisa do Estado de Minas Gerais
Minas Gerais, Brazil
Patent: 1
Universidade Federal de Minas Gerais
Minas Gerais, Brazil
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 24 patents in last 5 years, we discover 5 new entrants. Regeneron Pharmaceuticals, Inc., Oxford University Innovation Ltd., Glaxosmithkline Intellectual Property Development Ltd. are the most active new entrants in this area.
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 12
Oxford University Innovation Ltd.
United Kingdom
Patent: 8
Glaxosmithkline Intellectual Property Development Ltd.
East Sussex, United Kingdom
Patent: 2
Fundação de Amparo à Pesquisa do Estado de Minas Gerais
Minas Gerais, Brazil
Patent: 1
Universidade Federal de Minas Gerais
Minas Gerais, Brazil
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 25 patents, we discovered top 8 universities and scientific research institutions by total patent application. University of Cape Town, The University of North Carolina at Chapel Hill, Statens Serum Institute are dominant in this area. They take 64.00% of the total patent filing.
University of Cape Town
South Africa
Patent: 6
The University of North Carolina at Chapel Hill
North Carolina, United States
Patent: 5
Statens Serum Institute
Denmark
Patent: 4
Osaka University
Osaka-fu, Japan
Patent: 1
Universidade Federal de Minas Gerais
Minas Gerais, Brazil
Patent: 1
Gunma University
Japan
Patent: 1
Guangdong Pharmaceutical University
Guangdong Sheng, China
Patent: 1
Institute of Basic Medical Sciences
Beijing Shi, China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: